Corporate Profile
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias.

We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
IRTC (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.75 (1.19%)
Data as of 03/21/18 1:45 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: IRTC.O.  Currently trading at $63.86 with a 52 week high of $68.07 and a 52 week low of $32.10.
Recent News
03/10/18Zio by iRhythm Shown to Improve Detection of Previously Undiagnosed Atrial FibrillationPrinter Friendly Version
02/14/18iRhythm Technologies Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Full Year 2018 Financial OutlookPrinter Friendly Version
02/07/18iRhythm Technologies to Present at the RBC Global Healthcare ConferencePrinter Friendly Version
Upcoming Events
iRhythm Technologies Inc Annual Shareholder Meeting
Location 650 Townsend Street, Suite 500
San Francisco, CA 94103